These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 12697643

  • 21. Factors compromising the activity of moxifloxacin against intracellular Staphylococcus aureus.
    Nguyen HA, Grellet J, Dubois V, Saux MC, Quentin C.
    J Antimicrob Chemother; 2007 Apr; 59(4):755-8. PubMed ID: 17353222
    [Abstract] [Full Text] [Related]

  • 22. Capsaicin, a novel inhibitor of the NorA efflux pump, reduces the intracellular invasion of Staphylococcus aureus.
    Kalia NP, Mahajan P, Mehra R, Nargotra A, Sharma JP, Koul S, Khan IA.
    J Antimicrob Chemother; 2012 Oct; 67(10):2401-8. PubMed ID: 22807321
    [Abstract] [Full Text] [Related]

  • 23. Effect of recombinant human gamma interferon on intracellular activities of antibiotics against Listeria monocytogenes in the human macrophage cell line THP-1.
    Scorneaux B, Ouadrhiri Y, Anzalone G, Tulkens PM.
    Antimicrob Agents Chemother; 1996 May; 40(5):1225-30. PubMed ID: 8723471
    [Abstract] [Full Text] [Related]

  • 24. [Investigation of the effect of efflux pump inhibitors to MIC values of ciprofloxacin in clinical isolates of Pseudomonas aeruginosa, Escherichia coli, Acinetobacter baumannii and Staphylococcus aureus].
    Cetinkaya E, Coban AY, Durupinar B.
    Mikrobiyol Bul; 2008 Oct; 42(4):553-61. PubMed ID: 19149076
    [Abstract] [Full Text] [Related]

  • 25. Activity of three {beta}-lactams (ertapenem, meropenem and ampicillin) against intraphagocytic Listeria monocytogenes and Staphylococcus aureus.
    Lemaire S, Van Bambeke F, Mingeot-Leclercq MP, Tulkens PM.
    J Antimicrob Chemother; 2005 Jun; 55(6):897-904. PubMed ID: 15860552
    [Abstract] [Full Text] [Related]

  • 26. Intracellular accumulation and activity of ampicillin used as free drug and as its phthalimidomethyl or pivaloyloxymethyl ester (pivampicillin) against Listeria monocytogenes in J774 macrophages.
    Chanteux H, Mingeot-Leclercq MP, Sonveaux E, Van Bambeke F, Tulkens PM.
    J Antimicrob Chemother; 2003 Oct; 52(4):610-5. PubMed ID: 12972457
    [Abstract] [Full Text] [Related]

  • 27. Intracellular activity of azithromycin against Mycobacterium avium complex in human macrophages.
    Wildfeuer A, Haberreiter A.
    Arzneimittelforschung; 1997 Jul; 47(7):866-8. PubMed ID: 9272246
    [Abstract] [Full Text] [Related]

  • 28. Intracellular accumulation of linezolid in Escherichia coli, Citrobacter freundii and Enterobacter aerogenes: role of enhanced efflux pump activity and inactivation.
    Schumacher A, Trittler R, Bohnert JA, Kümmerer K, Pagès JM, Kern WV.
    J Antimicrob Chemother; 2007 Jun; 59(6):1261-4. PubMed ID: 16971414
    [Abstract] [Full Text] [Related]

  • 29. Mechanism of the intracellular killing and modulation of antibiotic susceptibility of Listeria monocytogenes in THP-1 macrophages activated by gamma interferon.
    Ouadrhiri Y, Scorneaux B, Sibille Y, Tulkens PM.
    Antimicrob Agents Chemother; 1999 May; 43(5):1242-51. PubMed ID: 10223943
    [Abstract] [Full Text] [Related]

  • 30. Influence of P-glycoprotein inhibitors on accumulation of macrolides in J774 murine macrophages.
    Seral C, Michot JM, Chanteux H, Mingeot-Leclercq MP, Tulkens PM, Van Bambeke F.
    Antimicrob Agents Chemother; 2003 Mar; 47(3):1047-51. PubMed ID: 12604540
    [Abstract] [Full Text] [Related]

  • 31. From phenothiazine to 3-phenyl-1,4-benzothiazine derivatives as inhibitors of the Staphylococcus aureus NorA multidrug efflux pump.
    Sabatini S, Kaatz GW, Rossolini GM, Brandini D, Fravolini A.
    J Med Chem; 2008 Jul 24; 51(14):4321-30. PubMed ID: 18578473
    [Abstract] [Full Text] [Related]

  • 32. Influence of the cell wall on ciprofloxacin susceptibility in selected wild-type Gram-negative and Gram-positive bacteria.
    Berlanga M, Montero MT, Hernández-Borrell J, Viñas M.
    Int J Antimicrob Agents; 2004 Jun 24; 23(6):627-30. PubMed ID: 15194135
    [Abstract] [Full Text] [Related]

  • 33. The pharmacodynamic properties of azithromycin in a kinetics-of-kill model and implications for bacterial conjunctivitis treatment.
    Dorfman MS, Wagner RS, Jamison T, Bell B, Stroman DW.
    Adv Ther; 2008 Mar 24; 25(3):208-17. PubMed ID: 18369536
    [Abstract] [Full Text] [Related]

  • 34. Inhibition of TNF-alpha production in THP-1 macrophages by glatiramer acetate does not alter their susceptibility to infection by Listeria monocytogenes and does not impair the efficacy of ampicillin or moxifloxacin against intracellular bacteria.
    Ben Abdelaziz H, Lemaire S, Carryn S, Van Bambeke F, Mingeot-Leclercq MP, Tulkens PM.
    J Antimicrob Chemother; 2004 Jul 24; 54(1):288-9. PubMed ID: 15190038
    [No Abstract] [Full Text] [Related]

  • 35. Evaluation of the extracellular and intracellular activities (human THP-1 macrophages) of telavancin versus vancomycin against methicillin-susceptible, methicillin-resistant, vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus.
    Barcia-Macay M, Lemaire S, Mingeot-Leclercq MP, Tulkens PM, Van Bambeke F.
    J Antimicrob Chemother; 2006 Dec 24; 58(6):1177-84. PubMed ID: 17062609
    [Abstract] [Full Text] [Related]

  • 36. Pharmacodynamic evaluation of the intracellular activities of antibiotics against Staphylococcus aureus in a model of THP-1 macrophages.
    Barcia-Macay M, Seral C, Mingeot-Leclercq MP, Tulkens PM, Van Bambeke F.
    Antimicrob Agents Chemother; 2006 Mar 24; 50(3):841-51. PubMed ID: 16495241
    [Abstract] [Full Text] [Related]

  • 37. Cellular pharmacokinetics and pharmacodynamics of the glycopeptide antibiotic oritavancin (LY333328) in a model of J774 mouse macrophages.
    Van Bambeke F, Carryn S, Seral C, Chanteux H, Tyteca D, Mingeot-Leclercq MP, Tulkens PM.
    Antimicrob Agents Chemother; 2004 Aug 24; 48(8):2853-60. PubMed ID: 15273091
    [Abstract] [Full Text] [Related]

  • 38. Polyamine effects on antibiotic susceptibility in bacteria.
    Kwon DH, Lu CD.
    Antimicrob Agents Chemother; 2007 Jun 24; 51(6):2070-7. PubMed ID: 17438056
    [Abstract] [Full Text] [Related]

  • 39. Activities of antistaphylococcal antibiotics towards the extracellular and intraphagocytic forms of Staphylococcus aureus isolates from a patient with persistent bacteraemia and endocarditis.
    Lemaire S, Kosowska-Shick K, Julian K, Tulkens PM, Van Bambeke F, Appelbaum PC.
    Clin Microbiol Infect; 2008 Aug 24; 14(8):766-77. PubMed ID: 18727801
    [Abstract] [Full Text] [Related]

  • 40. Pharmacodynamic activity of azithromycin against macrolide-susceptible and -resistant Streptococcus pneumoniae simulating clinically achievable free serum, epithelial lining fluid and middle ear fluid concentrations.
    Zhanel GG, DeCorby M, Noreddin A, Mendoza C, Cumming A, Nichol K, Wierzbowski A, Hoban DJ.
    J Antimicrob Chemother; 2003 Jul 24; 52(1):83-8. PubMed ID: 12775677
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.